AT
Apple Tree Partners
Venture CapitalActiveApple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
39
Investments
9
Exits
$1.2B
AUM
23.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Apple Tree Partners.
Investment Thesis & Strategy
Apple Tree Partners invests in various stages of pharmaceutical, biotech, medtech, and healthcare services companies. They seek to invest in companies that are making an impact in the healthcare industry.
Notable Exits
CompanyTypeYearValue / Acquirer
VtesseAcquisition2019—
Tetraphase PharmaceuticalsIPO2015—
Aratana TherapeuticsIPO2013—
Portola PharmaceuticalsIPO2013—
Sucampo PharmaceuticalsIPO2013—
Amicus TherapeuticsIPO2013—
Esperion TherapeuticsIPO2013—
Aegerion PharmaceuticalsIPO2012—
Synergy PharmaceuticalsIPO2007—
Frequently Asked Questions
Apple Tree Partners focuses on Series A, Series B, Series C+ stage investments.